Cargando…
Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates
Antibody–drug conjugates (ADCs) have emerged as the most promising strategy in targeted cancer treatment. Recent strategies for the optimization ADCs include the development of antibody fragment–drug conjugates (FDCs). The critical factor in the successful development of ADCs and FDCs is the identif...
Autores principales: | Kim, Eunhee G., Jeong, Jieun, Lee, Junghyeon, Jung, Hyeryeon, Kim, Minho, Zhao, Yi, Yi, Eugene C., Kim, Kristine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355425/ https://www.ncbi.nlm.nih.gov/pubmed/32630402 http://dx.doi.org/10.3390/biom10060955 |
Ejemplares similares
-
Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
por: Kim, Eunhee G., et al.
Publicado: (2015) -
Cysteine-to-lysine transfer antibody fragment conjugation
por: Forte, Nafsika, et al.
Publicado: (2019) -
Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics'
por: Schumacher, Felix F., et al.
Publicado: (2013) -
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
por: Schwach, Jonathan, et al.
Publicado: (2020) -
Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysis
por: Seo, Yu Ri, et al.
Publicado: (2023)